Wang, Zekun
Liu, Wenyang
Zhang, Jianghu
Chen, Xuesong
Wang, Jingbo
Wang, Kai
Qu, Yuan
Huang, Xiaodong
Luo, Jingwei
Xiao, Jianping
Xu, Guozhen
Gao, Li
Yi, Junlin
Zhang, Ye
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2017B17)
Article History
Received: 2 December 2021
Accepted: 24 April 2022
First Online: 30 May 2022
Change Date: 24 June 2022
Change Type: Update
Change Details: In this article the title was incorrectly given as “Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and heck squamous cell carcinoma: a prospective phase II trial” but should have been “Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial”.
Declarations
:
: Z. Wang, W. Liu, J. Zhang, X. Chen, J. Wang, K. Wang, Y. Qu, X. Huang, J. Luo, J. Xiao, G. Xu, L. Gao, J. Yi, and Y. Zhang declare that they have no competing interests.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No.17-115/1371). Informed consent was obtained from all individual participants included in the study.
Free to read: This content has been made available to all.